PORTACCI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 70
EU - Europa 36
AS - Asia 30
Totale 136
Nazione #
US - Stati Uniti d'America 69
SG - Singapore 25
DE - Germania 11
IT - Italia 10
CZ - Repubblica Ceca 5
SE - Svezia 5
IN - India 4
LT - Lituania 3
IE - Irlanda 2
CA - Canada 1
CN - Cina 1
Totale 136
Città #
New York 18
Chandler 16
Singapore 16
Munich 10
Ashburn 5
Milan 5
Nyköping 5
Olomouc 4
Dublin 2
Mumbai 2
Pune 2
Seattle 2
Brno 1
Los Angeles 1
Ottawa 1
Rome 1
San Severo 1
Shanghai 1
Totale 93
Nome #
A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation 23
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure 19
The impact of healthcare setting on post-COVID mood disorders: a single-centre perspective from Southern Italy Respiratory Intensive Care Unit 17
Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study 15
Asthma and Fixed Airways Obstruction: Real Life Aspects 10
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 8
The Predictors of Long COVID in Southeastern Italy 7
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 6
Advancing Care in Severe Asthma: The Art of Switching Biologics 6
Assessment of Five Questionnaires for Chronic Obstructive Pulmonary Disease in a Southern Italian Population: A Proof-of-Concept Study 5
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 5
Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience 4
Reply to "Have we reached our final destination with biologics in severe uncontrolled asthma?" 4
Effect of Food Intake on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose 4
Super-Responders to Biologic Treatment in Type 2-High Severe Asthma: Passing Fad or a Meaningful Phenotype? 3
Can single-inhaler Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium therapy postpone or save biologics for severe asthma? 3
Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development? 3
Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry 2
Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma” 2
Female gender and psychological profile of outpatients attending Post-COVID-19 follow-up: some preliminary results 2
Short-term Tezepelumab effectiveness in patients with severe asthma: a multicentre study 2
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 2
Electronic Nose Analysis of Exhaled Breath Volatile Organic Compound Profiles during Normoxia, Hypoxia, and Hyperoxia 2
Divergences in chronic cough management among healthcare professionals in Southern Italy: A comprehensive survey 2
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 2
Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review 1
Type-2 severe asthma comorbidities in the era of biologics: time to rethink clinical response? 1
Totale 160
Categoria #
all - tutte 2.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202341 0 0 0 2 6 9 0 6 8 1 5 4
2023/202460 6 5 3 5 7 21 0 2 5 0 1 5
2024/202559 23 12 0 22 2 0 0 0 0 0 0 0
Totale 160